# Clinical Evaluation of the Free Margin Cusp Sizer (CALIBRATE)

Study · id `cardio:ct-nct04797572` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04797572](<https://clinicaltrials.gov/study/NCT04797572>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04797572

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT04797572. Allocation not applicable; no masking; primary purpose treatment. Start 2021-03-22 (actual); primary completion 2026-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT04797572, source copy `cardio:ctgov-nct04797572-2025-05-16`, retrieved 2026-10-26)
- Started: 2021-03-22 (actual) (ClinicalTrials.gov record NCT04797572, source copy `cardio:ctgov-nct04797572-2025-05-16`, retrieved 2026-10-26)
- Primary completion: 2026-06-30 (anticipated) (ClinicalTrials.gov record NCT04797572, source copy `cardio:ctgov-nct04797572-2025-05-16`, retrieved 2026-10-26)
- Completion: 2027-12-30 (anticipated) (ClinicalTrials.gov record NCT04797572, source copy `cardio:ctgov-nct04797572-2025-05-16`, retrieved 2026-10-26)
- Countries: Belgium (ClinicalTrials.gov record NCT04797572, source copy `cardio:ctgov-nct04797572-2025-05-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04797572-2025-05-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Evaluation of the Free Margin Cusp Sizer (CALIBRATE)
- Acronym: CALIBRATE
- Condition: Aortic Valve Regurgitation
- Condition: Aortic Root Aneurysm
- Intervention (Device): Free Margin Cusp Sizer
- Lead sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry condition terms include this condition: Aortic regurgitation (`cardio:aortic-regurgitation`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Thoracic aortic aneurysm (`cardio:thoracic-aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain (`cardio:org-cliniques-universitaires-saint-luc-universite-catholique-de-a23a89`)

## Provenance

Content hash: 3cfed07ac0cc3d2d53a919568b41ad627bc2bbfed4a731f5ba9f799edc63c054
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
